These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7188753)

  • 1. The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1980 Jan; 61(2):99-109. PubMed ID: 7188753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the role of cholinergic mechanisms in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1979 Jun; 56(1-2):115-21. PubMed ID: 157281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary studies on increased naloxone potency and its relationship to morphine tolerance and dependence in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1980; 7(3):305-10. PubMed ID: 7190475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the cholinergic system in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1978 Aug; 50(3):221-30. PubMed ID: 567586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator.
    Nakagawa T; Ozawa T; Shige K; Yamamoto R; Minami M; Satoh M
    Eur J Pharmacol; 2001 May; 419(1):39-45. PubMed ID: 11348628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced naloxone potency and the development of narcotic tolerance.
    Tulunay FC; Yano I; Takemori AE
    Eur J Pharmacol; 1979 Jan; 53(3):247-53. PubMed ID: 759202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of morphine-induced tolerance and physical dependence by prolyl-leucyl-glycinamide.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1981 May; 71(2-3):259-68. PubMed ID: 6113968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
    Naidu PS; Singh A; Joshi D; Kulkarni SK
    Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucosamine against morphine-induced antinociceptive tolerance and dependence in mice.
    Basiri F; Rad A; Mahdian D; Molavi M; Amin B
    J Biomed Sci; 2019 Feb; 26(1):21. PubMed ID: 30782159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors.
    Smith FL; Javed R; Elzey MJ; Welch SP; Selley D; Sim-Selley L; Dewey WL
    Brain Res; 2002 Dec; 958(1):28-35. PubMed ID: 12468027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.